SCHEMBL10183039

SCHEMBL10183039

CC(=O)Oc1cc(CCc2cc(OC(C)=O)cc(OC(C)=O)c2)cc(OC(C)=O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.58
CYP4A11 Q02928 1/20 0.58
LMNA P02545 4/20 0.50
MAPT P10636 3/20 0.50
KDM4E B2RXH2 3/20 0.50
CYP3A4 P08684 2/20 0.50
TP53 P04637 2/20 0.50
MEN1 O00255 1/20 0.50
TTR P02766 1/20 0.50
KMT2A Q03164 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CYP19A1 P11511 1/20 0.46
BACE1 P56817 1/20 0.44
ALOX5 P09917 2/20 0.44
ALDH1A1 P00352 1/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
MAPK1 P28482 1/20 0.44
CASP1 P29466 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1379954 0.92 CYP4F2 (0.56) CYP4F2CYP4A11LMNAMAPTKDM4E
SCHEMBL718523 0.90 MAPT (0.56) CYP4F2CYP4A11LMNAMAPTKDM4E
SCHEMBL10149317 0.90 LMNA (0.52) CYP4F2CYP4A11LMNAMAPTKDM4E
SCHEMBL1382107 0.90 CYP4F2 (0.50) CYP4F2CYP4A11LMNAMAPTKDM4E
SCHEMBL10149033 0.88 SMN1; SMN2 (0.55) CYP4F2CYP4A11LMNAMAPTKDM4E
SCHEMBL1381833 0.88 CYP4F2 (0.49) CYP4F2CYP4A11LMNAMAPTKDM4E
SCHEMBL2010436 0.87 LMNA (0.59) CYP4F2CYP4A11LMNAMAPTKDM4E
SCHEMBL10148975 0.87 LMNA (0.60) CYP4F2CYP4A11LMNAMAPTKDM4E
SCHEMBL462587 0.87 ALOX5 (0.57) CYP4F2CYP4A11CYP3A4ALOX5
SCHEMBL722695 0.87 CYP4F2 (0.47) CYP4F2CYP4A11LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200188878-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2020-06-18 US disclosed
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-10-06 US disclosed
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2012-03-01 US disclosed
WO-2010085851-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 CYP4F2 1710/4885CYP4A11 773/4885LMNA 3479/4885
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 CYP4F2 1710/4885CYP4A11 773/4885LMNA 3479/4885
US-20200188878-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 CYP4F2 1710/4885CYP4A11 773/4885LMNA 3479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.